These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18693392)

  • 1. Molecule of the month.
    Lindsley CW
    Curr Top Med Chem; 2008; 8(12):1100. PubMed ID: 18693392
    [No Abstract]   [Full Text] [Related]  

  • 2. PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.
    Ceska R; Stulc T; Zima T; Malbohan I; Fialova L
    Atherosclerosis; 2003 Jan; 166(1):195-6. PubMed ID: 12482567
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
    Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
    Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Religious attendance: more cost-effective than lipitor?
    Denberg T
    J Am Board Fam Med; 2006; 19(4):430; author reply 431-3. PubMed ID: 16809663
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia.
    Stein DT; Devaraj S; Balis D; Adams-Huet B; Jialal I
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2026-31. PubMed ID: 11742880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin: in the management of hyperlipidaemia.
    Ray SK; Rege NN
    J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodents.
    Holub JM; O'Toole-Colin K; Getzel A; Argenti A; Evans MA; Smith DC; Dalglish GA; Rifat S; Wilson DL; Taylor BM; Miott U; Glersaye J; Lam KS; McCranor BJ; Berkowitz JD; Miller RB; Lukens JR; Krumpe K; Gupton JT; Burnham BS
    Molecules; 2004 Feb; 9(3):134-57. PubMed ID: 18007418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
    Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
    J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A closer look at Caduet. The new generation of combination treatment.
    Brock CM; Pitcock J
    Adv Nurse Pract; 2005 Jan; 13(1):31-3. PubMed ID: 15679289
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus.
    Van JT; Pan J; Wasty T; Chan E; Wu X; Charles MA
    Am J Cardiol; 2002 Jun; 89(11):1306-8. PubMed ID: 12031735
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.
    Taldone T; Zito SW; Talele TT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):479-84. PubMed ID: 18068977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streamlined catalytic asymmetric synthesis of atorvastatin.
    Kawato Y; Chaudhary S; Kumagai N; Shibasaki M
    Chemistry; 2013 Mar; 19(12):3802-6. PubMed ID: 23436316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effect of lemongrass oil against dexamethasone induced hyperlipidemia in rats: possible role of decreased lecithin cholesterol acetyl transferase activity.
    Kumar VR; Inamdar MN; Nayeemunnisa ; Viswanatha GL
    Asian Pac J Trop Med; 2011 Aug; 4(8):658-60. PubMed ID: 21914547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: rosuvastatin--an efficacy assessment based on pooled trial data.
    Stein EA
    Am J Cardiol; 2003 Mar; 91(5A):1C-2C. PubMed ID: 12646335
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of atorvastatin and fenofibrate on autonomic tone in subjects with combined hyperlipidemia.
    Melenovsky V; Wichterle D; Simek J; Malik J; Haas T; Ceska R; Malik M
    Am J Cardiol; 2003 Aug; 92(3):337-41. PubMed ID: 12888150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism.
    Hiyoshi H; Yanagimachi M; Ito M; Saeki T; Yoshida I; Okada T; Ikuta H; Shinmyo D; Tanaka K; Kurusu N; Tanaka H
    Eur J Pharmacol; 2001 Nov; 431(3):345-52. PubMed ID: 11730728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia.
    Okopien B; Huzarska M; Kulach A; Stachura-Kulach A; Madej A; Belowski D; Zielinski M; Herman ZS
    J Cardiovasc Pharmacol; 2005 Feb; 45(2):160-4. PubMed ID: 15654265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.